US Stock MarketDetailed Quotes

NBIX Neurocrine Biosciences

Watchlist
  • 118.010
  • -0.450-0.38%
Close Oct 18 16:00 ET
  • 118.010
  • 0.0000.00%
Post 20:01 ET
11.92BMarket Cap35.55P/E (TTM)

Neurocrine Biosciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Neurocrine Biosciences Q3 2024 Estimates Date

Currency：USDOct 30, 2024

Estimate YoY
Revenue
603.14M
+20.92%
EPS
1.44
+76.10%
Analyst Rating
Strong Buy

Oct 20, 2024

Neurocrine Biosciences Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 21 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 622.211M--
Oct 30, 20242024/Q3-- / 603.144M--
Aug 1, 20242024/Q2590.200M / 546.595M--
May 1, 20242024/Q1515.300M / 512.006M--
Feb 7, 20242023/Q4515.200M / 518.389M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 622.211M--
Oct 30, 20242024/Q3-- / 603.144M--
Aug 1, 20242024/Q2590.200M / 546.595M--
May 1, 20242024/Q1515.300M / 512.006M--
Feb 7, 20242023/Q4515.200M / 518.389M--

Unlock Free Earnings Estimates

Neurocrine Biosciences Earnings Reports

  • Neurocrine Biosciences | 10-Q: Q2 2024 Earnings Report

    Aug 1 07:07 ET

  • Neurocrine Biosciences | 10-Q: Q1 2024 Earnings Report

    May 1 07:09 ET

  • Neurocrine Biosciences | 10-K: FY2023 Annual Report

    Feb 9 17:31 ET

  • Neurocrine Biosciences | 10-Q: Q3 2023 Earnings Report

    Oct 31, 2023 07:02 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Oct 20, 2024

    Strong Buy

    • Buy

      78.26%

    • Hold

      21.74%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data